Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongsheng Tu

Showing results (51-60 of 200) with videos related to

Pageof 20
Sort By:
Breast Cancer Research and Treatment|July 28, 2020
Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trialVikki Ho, Romain Pasquet, Shaman Luo, et al.
Breast Cancer Research and Treatment|October 24, 2012
Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-studyKishor M Wasan, Paul E Goss, P Haydn Pritchard, et al.
Breast Cancer Research and Treatment|July 11, 2006
Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19Jianhua Liu, Dongsheng Tu, Janet Dancey, et al.
Pain|September 7, 2023
Randomized, double-blind, controlled trial of a combination of alpha-lipoic acid and pregabalin for neuropathic pain: the PAIN-CARE trialIan Gilron, Sylvia Robb, Dongsheng Tu, et al.
Pain|May 13, 2025
Melatonin for neuropathic pain: a double-blind, placebo-controlled, randomized, crossover trialIan Gilron, Hala Elkerdawy, Dongsheng Tu, et al.
JMIR Research Protocols|March 30, 2017
Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia PainIan Gilron, Dongsheng Tu, Ronald Holden, et al.
The New England Journal of Medicine|April 1, 2005
Morphine, gabapentin, or their combination for neuropathic painIan Gilron, Joan M Bailey, Dongsheng Tu, et al.
Lancet (London, England)|October 3, 2009
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trialIan Gilron, Joan M Bailey, Dongsheng Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5Mark N Levine, Kathleen I Pritchard, Vivien H C Bramwell, et al.
Breast Cancer Research and Treatment|November 26, 2021
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17RYapeng Li, Xueying Zheng, Dongsheng Tu, et al.
Pageof 20

Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
Breast Cancer Research and Treatment|July 28, 2020
Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trialVikki Ho, Romain Pasquet, Shaman Luo, et al.
Breast Cancer Research and Treatment|October 24, 2012
Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-studyKishor M Wasan, Paul E Goss, P Haydn Pritchard, et al.
Breast Cancer Research and Treatment|July 11, 2006
Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19Jianhua Liu, Dongsheng Tu, Janet Dancey, et al.
Pain|September 7, 2023
Randomized, double-blind, controlled trial of a combination of alpha-lipoic acid and pregabalin for neuropathic pain: the PAIN-CARE trialIan Gilron, Sylvia Robb, Dongsheng Tu, et al.
Pain|May 13, 2025
Melatonin for neuropathic pain: a double-blind, placebo-controlled, randomized, crossover trialIan Gilron, Hala Elkerdawy, Dongsheng Tu, et al.
JMIR Research Protocols|March 30, 2017
Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia PainIan Gilron, Dongsheng Tu, Ronald Holden, et al.
The New England Journal of Medicine|April 1, 2005
Morphine, gabapentin, or their combination for neuropathic painIan Gilron, Joan M Bailey, Dongsheng Tu, et al.
Lancet (London, England)|October 3, 2009
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trialIan Gilron, Joan M Bailey, Dongsheng Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5Mark N Levine, Kathleen I Pritchard, Vivien H C Bramwell, et al.
Breast Cancer Research and Treatment|November 26, 2021
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17RYapeng Li, Xueying Zheng, Dongsheng Tu, et al.
Pageof 20